Hahm, Eun-Ryeong <br/><br/>
Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis.  [electronic resource] 

 -  Biochemical and biophysical research communications  Aug 2004 
 - 337-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-291X 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2004.06.119  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--chemical synthesis<br/>Animals<br/>Antineoplastic Agents--chemical synthesis<br/>Cell Line, Tumor<br/>Cell Movement<br/>Chick Embryo<br/>Curcumin--analogs & derivatives<br/>Down-Regulation--drug effects<br/>Humans<br/>Matrix Metalloproteinase 9--genetics<br/>Neoplasm Invasiveness<br/>Neoplasms--blood supply<br/>Neovascularization, Pathologic--drug therapy<br/>Promoter Regions, Genetic--genetics<br/>Proto-Oncogene Proteins c-jun--genetics<br/>RNA, Messenger--genetics<br/>Tetradecanoylphorbol Acetate--antagonists & inhibitors<br/>Transcription Factor AP-1--genetics<br/>Transcription, Genetic--drug effects<br/>Umbilical Cord--pathology<br/>Vascular Endothelial Growth Factor A--genetics